Pierre Fabre Laboratories’ new Dubai hub highlights bold plans for regional growth

Pierre Fabre Laboratories Group, a dermo-cosmetics and pharmaceutical giant, has unveiled its plans for expansion in the Middle East with the launch of a new regional hub in Dubai. The company, which includes well-known brands such as Avène, Ducray, A-Derma, Klorane, and René Furterer, is a global player in the healthcare industry.

Eric Ducournau, the CEO of Pierre Fabre Laboratories, officially opened the new premises, which will serve as the headquarters for the company's Middle East, Africa, Russia, Turkey (MEART) subsidiary. Ducournau emphasized that the move underscores the company's commitment to expanding its presence in the region and its aim to double sales within six years.

He highlighted Dubai's political stability, investment in science, and strong healthcare commitment as key reasons for choosing the city as the regional center. Pierre Fabre Laboratories aims to continue its research into "the medicines of the future" while adapting existing treatments to meet regional needs. The company works closely with healthcare professionals to understand patients' needs and is committed to developing products with the support of scientific partnerships.

Ducournau stressed the importance of scientific collaborations and the availability of advanced hospitals, equipment, and experienced doctors in Dubai. The company also highlights its dedication to corporate social responsibility and environmentally friendly practices. Founded in 1961 by pharmacist Pierre Fabre, the group has since expanded its activities to include dermo-cosmetics and pharmaceuticals, with a focus on oncology and dermatology.

Pierre Fabre Laboratories operates in 44 countries and is the world's second-largest player in the dermo-cosmetics market and France's fourth-largest pharmaceutical company.